TY - JOUR
T1 - Depressive symptomatology in school-aged children with obstructive sleep apnea syndrome
T2 - Incidence, demographic factors, and changes following a randomized controlled trial of adenotonsillectomy
AU - Hodges, Elise
AU - Marcus, Carole L.
AU - Kim, Ji Young
AU - Xanthopoulos, Melissa
AU - Shults, Justine
AU - Giordani, Bruno
AU - Beebe, Dean W.
AU - Rosen, Carol L.
AU - Chervin, Ronald D.
AU - Mitchell, Ron B.
AU - Katz, Eliot S.
AU - Gozal, David
AU - Redline, Susan
AU - Elden, Lisa
AU - Arens, Raanan
AU - Moore, Renee
AU - Taylor, H. Gerry
AU - Radcliffe, Jerilynn
AU - Thomas, Nina H.
N1 - Funding Information:
The study was funded by National Institutes of Health grants HL083075, HL083129, and UL 1 TR000003. The study was also supported by a Scientific Coordinating Center / Sleep Reading Center at Brigham and Women’s Hospital (Boston, MA). Conflict of interest statement. E.H., C.L.M., J.Y.K., J.S., B.G., D.W.B., R.B.M., E.S.K., D.G., S.R., L.E., R.A., R.M., H.G.T., J.R., and N.H.T. have no financial or nonfinancial disclosures. M.X. has received salary support through a research agreement from Eisai Inc. to the Children’s Hospital of Philadelphia for a project unrelated to the current manuscript. C.L.R. is on the board of directors of the American Academy of Sleep Medicine, is involved with investigational drugs/devices with JazzPharmaceutical and Flamel, and has been a consultant for Jazz Pharmaceutical and Advance-Medical; not related to the current article. R.D.C. receives research support from the NIH and Michigan Medicine. He serves on the boards of directors for the International Pediatric Sleep Association, the nonprofit Sweet Dreamzzz, Inc, and the American Academy of Sleep Medicine. He is President of the Associated Professional Sleep Societies. He serves as an editor and author for UpToDate.
Publisher Copyright:
© 2018 Sleep Research Society.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Study Objectives Depressive symptoms following adenotonsillectomy (AT) relative to controls were examined in children with obstructive sleep apnea syndrome (OSAS). Methods The Childhood Adenotonsillectomy Trial (CHAT) multisite study examined the impact of AT in 453 children aged 5 to 9.9 years with polysomnographic evidence of OSAS without prolonged desaturation, randomized to early adenotonsillectomy (eAT) or watchful waiting with supportive care (WWSC). One hundred seventy-six children (eAT n = 83; WWSC n = 93) with complete evaluations for depressive symptomatology between baseline and after a 7-month intervention period were included in this secondary analysis. Results Exact binomial test assessed proportion of depressive symptomatology relative to norms, while effects of AT and OSAS resolution were assessed through linear quantile mixed-models. Treatment group assignment did not significantly impact depression symptoms, although self-reported depression symptoms improved over time (p < 0.001). Resolution of OSAS symptoms demonstrated a small interaction effect in an unexpected direction, with more improvement in parent ratings of anxious/depressed symptoms for children without resolution (p = 0.030). Black children reported more severe depressive symptoms (p = 0.026) and parents of overweight/obese children reported more withdrawn/depressed symptoms (p = 0.004). Desaturation nadir during sleep was associated with self-report depressed (r = 0.17, p = 0.028), parent-reported anxious/depressed (r = 0.15, p = 0.049), and withdrawn/depressed (r = 0.24, p = 0.002) symptoms. Conclusions Increased risk for depressed and withdrawn/depressed symptoms was detected among children with OSAS, and different demographic variables contributed to risk in self-reported and parent-reported depression symptoms. Arterial oxygen desaturation nadir during sleep was strongly associated with depressed symptoms. However, despite improvements in child-reported depressed symptoms over time, changes were unrelated to either treatment group or OSAS resolution status. Trials Registration Childhood Adenotonsillectomy Study for Children with OSAS (CHAT), https://clinicaltrials.gov/show/NCT00560859, NCT00560859.
AB - Study Objectives Depressive symptoms following adenotonsillectomy (AT) relative to controls were examined in children with obstructive sleep apnea syndrome (OSAS). Methods The Childhood Adenotonsillectomy Trial (CHAT) multisite study examined the impact of AT in 453 children aged 5 to 9.9 years with polysomnographic evidence of OSAS without prolonged desaturation, randomized to early adenotonsillectomy (eAT) or watchful waiting with supportive care (WWSC). One hundred seventy-six children (eAT n = 83; WWSC n = 93) with complete evaluations for depressive symptomatology between baseline and after a 7-month intervention period were included in this secondary analysis. Results Exact binomial test assessed proportion of depressive symptomatology relative to norms, while effects of AT and OSAS resolution were assessed through linear quantile mixed-models. Treatment group assignment did not significantly impact depression symptoms, although self-reported depression symptoms improved over time (p < 0.001). Resolution of OSAS symptoms demonstrated a small interaction effect in an unexpected direction, with more improvement in parent ratings of anxious/depressed symptoms for children without resolution (p = 0.030). Black children reported more severe depressive symptoms (p = 0.026) and parents of overweight/obese children reported more withdrawn/depressed symptoms (p = 0.004). Desaturation nadir during sleep was associated with self-report depressed (r = 0.17, p = 0.028), parent-reported anxious/depressed (r = 0.15, p = 0.049), and withdrawn/depressed (r = 0.24, p = 0.002) symptoms. Conclusions Increased risk for depressed and withdrawn/depressed symptoms was detected among children with OSAS, and different demographic variables contributed to risk in self-reported and parent-reported depression symptoms. Arterial oxygen desaturation nadir during sleep was strongly associated with depressed symptoms. However, despite improvements in child-reported depressed symptoms over time, changes were unrelated to either treatment group or OSAS resolution status. Trials Registration Childhood Adenotonsillectomy Study for Children with OSAS (CHAT), https://clinicaltrials.gov/show/NCT00560859, NCT00560859.
KW - depression
KW - mental health
KW - neuropsychology
KW - obstructive sleep apnea
KW - pediatrics - sleep apnea
KW - sleep and psychiatric conditions
UR - http://www.scopus.com/inward/record.url?scp=85058568281&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058568281&partnerID=8YFLogxK
U2 - 10.1093/sleep/zsy180
DO - 10.1093/sleep/zsy180
M3 - Article
C2 - 30212861
AN - SCOPUS:85058568281
SN - 0161-8105
VL - 41
JO - Sleep
JF - Sleep
IS - 12
ER -